AR011011A1 - COMPOUNDS OF 3- [PIPERIDIN-4-IL] - AND 3- [1,2,3,6-TETRAHIDROPIRIDIN-4-IL] - PIRROL [3,2-B] -PIRIDINE-5-SUBSTITUTED USEFUL AS RECEPTOR AGONISTS 5-TH (1F), PROCEDURE FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS FORMULATED WITH SUCH COMPOUNDS - Google Patents

COMPOUNDS OF 3- [PIPERIDIN-4-IL] - AND 3- [1,2,3,6-TETRAHIDROPIRIDIN-4-IL] - PIRROL [3,2-B] -PIRIDINE-5-SUBSTITUTED USEFUL AS RECEPTOR AGONISTS 5-TH (1F), PROCEDURE FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS FORMULATED WITH SUCH COMPOUNDS

Info

Publication number
AR011011A1
AR011011A1 ARP970105321A AR011011A1 AR 011011 A1 AR011011 A1 AR 011011A1 AR P970105321 A ARP970105321 A AR P970105321A AR 011011 A1 AR011011 A1 AR 011011A1
Authority
AR
Argentina
Prior art keywords
phenyl
substituted
alkyl
compounds
cycloalkyl
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR011011A1 publication Critical patent/AR011011A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compuestos de 3-[piperidin-4-il] y 3-[1,2,3,6-tetrahidropiridil-4-il]- pirrol-[3,2-b]-piridina-5 sustituidos, utiles como agonistas de los receptores5HT(1F), que tienen la formula (I), en la que: A-B es -C=CH o -CH-CH2; R es H, alquilo C1-C6,b encilo o feniletilo; X es -NR1SO2R2, -NHC(Q)NR3R4, -NHC(O)OR5 o-NR1C(O)R6, donde: Q es O o S; R1 es H o alquilo C1-C4; R2 es alquilo C1-C4, fenilo o fenilo sustituido; R3 y R4 se seleccionan independientemente entre elgrupo compuesto por H,alquil o C1-C6, alquenilo C3-C6, cicloalquilo C3-C8, fenilo, fenilo sustituido, fenil(alquileno C1-C4), fenil(alquilenilo C1-C4)sustituido en el anillo fenilo, ((alquil C1-C4 o alcoxicarbonil C1-C4 sustituido)alquil C1-C4)fenilo,alquilo C1-C 4 alfa-sustituido conalcoxicarbonilo C1-C4, heteroarilo; o R3 y R4, tomados junto con el átomo de nitrogeno al que están unidos, forman un anillo de pirrolidina, piperidina,piperazina, piperazina 4-sustituida, morfolina otiomorfolina; R5 es alqui lo C1-C6, alquenilo C3-C6, fenilo, fenilo sustituido, cicloalquilo C3-C8, alquiloC1-C4 omega-sustituido con alcoxi C1-C4; R6 es alquilo C1-C10, alquilo C1-C10 sustituido, alquenilo C2-C10, alquinilo C2-C10,cicloalquilo C3-C8, fenilo,fenilo sust ituido, naftilo, fenil(alquileno C1-C4), fenil(alquileno C1-C4) sustituido en el anillo fenilo, 2-feniletilen-1-ilo, difenilmetilo,cicloalquilo C4-C8 condensado con benceno, alquileno C1-C4omega-sustituido con con cicloalquilo C3-C6, o un heter ociclo; y sales de adicion de ácidos ysolvatos de los mismos farmacéuticamente aceptables. Comprende formulaciones farmacéuticas que incluyen dichos compuestos de formula (I),utiles para tratar afecciones asociadas con la activacion de los receptores 5-HT(1F) empleando dichos compuestos, por ejemplo en composiciones formuladas conCompounds of 3- [piperidin-4-yl] and 3- [1,2,3,6-tetrahydropyridyl-4-yl] -pyrrole- [3,2-b] -pyridine-5, useful as agonists of the 5HT (1F) receptors, having formula (I), in which: AB is -C = CH or -CH-CH2; R is H, C1-C6 alkyl, b encyl or phenylethyl; X is -NR1SO2R2, -NHC (Q) NR3R4, -NHC (O) OR5 or -NR1C (O) R6, where: Q is O or S; R1 is H or C1-C4 alkyl; R2 is C1-C4 alkyl, phenyl, or substituted phenyl; R3 and R4 are independently selected from the group consisting of H, C1-C6-alkyl, C3-C6-alkenyl, C3-C8-cycloalkyl, phenyl, substituted phenyl, phenyl (C1-C4-alkylene) substituted in phenyl ring, ((C1-C4 alkyl or substituted C1-C4 alkoxycarbonyl) C1-C4 alkyl) phenyl, C1-C4 alkyl alpha-substituted with C1-C4alkoxycarbonyl, heteroaryl; or R3 and R4, taken together with the nitrogen atom to which they are attached, form a ring of pyrrolidine, piperidine, piperazine, 4-substituted piperazine, morpholine or otiomorpholine; R5 is C1-C6alkyl, C3-C6alkenyl, phenyl, substituted phenyl, C3-C8cycloalkyl, C1-C4alkyl omega-substituted with C1-C4alkoxy; R6 is C1-C10 alkyl, substituted C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, C3-C8 cycloalkyl, phenyl, substituted phenyl, naphthyl, phenyl (C1-C4 alkylene), phenyl (C1-C4 alkylene ) substituted on the phenyl ring, 2-phenylethylene-1-yl, diphenylmethyl, C4-C8 cycloalkyl fused with benzene, C1-C4alkylene-omega-substituted with C3-C6 cycloalkyl, or a heterocyl; and pharmaceutically acceptable acid addition salts and solvents thereof. It comprises pharmaceutical formulations including said compounds of formula (I), useful for treating conditions associated with the activation of 5-HT (1F) receptors using said compounds, for example in compositions formulated with

ARP970105321 1996-11-15 1997-11-13 COMPOUNDS OF 3- [PIPERIDIN-4-IL] - AND 3- [1,2,3,6-TETRAHIDROPIRIDIN-4-IL] - PIRROL [3,2-B] -PIRIDINE-5-SUBSTITUTED USEFUL AS RECEPTOR AGONISTS 5-TH (1F), PROCEDURE FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS FORMULATED WITH SUCH COMPOUNDS AR011011A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30395096P 1996-11-15 1996-11-15
US3095096P 1996-11-15 1996-11-15

Publications (1)

Publication Number Publication Date
AR011011A1 true AR011011A1 (en) 2000-08-02

Family

ID=45724841

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105321 AR011011A1 (en) 1996-11-15 1997-11-13 COMPOUNDS OF 3- [PIPERIDIN-4-IL] - AND 3- [1,2,3,6-TETRAHIDROPIRIDIN-4-IL] - PIRROL [3,2-B] -PIRIDINE-5-SUBSTITUTED USEFUL AS RECEPTOR AGONISTS 5-TH (1F), PROCEDURE FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS FORMULATED WITH SUCH COMPOUNDS

Country Status (1)

Country Link
AR (1) AR011011A1 (en)

Similar Documents

Publication Publication Date Title
AR002971A1 (en) COMPOUNDS OF 3- (1,2,3,6) -TETRAHIDROPIRIDIN-4-ILO AND 3-PIPERIDIN-4-ILO-1H- INDOL, AGONISTS OF 5HT (1f) CONTAINING PHARMACEUTICAL FORMULATIONS AND METHODS FOR ACTIVATING SUCH 5HT RECEPTORS ( 1f) AND / OR TO TREAT MIGRANES AND DISORDERS ASSOCIATED WITH IT.
AR055878A1 (en) CYCLOPROPANOCARBOXAMIDE DERIVATIVES
NO20025641D0 (en) Substituted 1-aminoalkyl lactams and their use as muscarinic receptor antagonists
ES2116583T3 (en) AZACICLIC COMPOUNDS, COMPOSITIONS CONTAINING THEM AND THEIR USE AS TACHYCIN ANTAGONISTS.
UY27322A1 (en) NEW INDOL DERIVATIVES WITH AFFINITY FOR THE 5-HT6 RECEIVER
UY26143A1 (en) USEFUL HETEROCYCLIC DERIVATIVES AS ANTI-CANCER AGENTS
CR7698A (en) NEW BENZOIMIDAZOL USEFUL DERIVATIVES AS ANTIPROLIFERATIVE AGENTS
PA8480101A1 (en) DERIVATIVES OF QUINOLIN-2-ONA ALQUINILS SUBSTITUTED USEFUL AS ANTI-TARGET AGENTS
DK0457686T3 (en) Novel aminopiperidine, aminopyrrolidine and amine operhydroazepine derivatives, processes for their preparation and pharmaceutical agents containing them
UY28135A1 (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH
NO20025640D0 (en) Substituted 1-aminoalkyl lactams and their use as muscarinic receptor antagonists
CO4900068A1 (en) PIPERAZINE DI - N - SUBSTITUTED AND PIPERIDINES 1,4-DI- SUBSTITUTED USEFUL AS MUSCARINIC ANTAGONISTS
AR016977A1 (en) INDOL COMPOUNDS 2,3-SUBSTITUTED AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS, PHARMACEUTICAL COMPOSITIONS, USE, USEFUL INTERMEDIARIES, PREPARATION PROCEDURES
PE20021004A1 (en) PIPERIDINE DERIVATIVES AS INHIBITORS OF CCR5
AR031526A1 (en) NEW PHENYLPIPERAZINES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, METHODS TO PREPARE COMPOUNDS AND COMPOSITIONS AND USE OF COMPOUNDS IN THE PREPARATION OF A MEDICINAL PRODUCT.
DE69018678T2 (en) Tricyclic lactam derivatives and pharmaceutical compositions containing them.
AR007108A1 (en) ANTI-TUMOR AND ANTIVIRAL RENTAL AGENTS, PROCEDURE FOR THEIR PREPARATION, USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH AGENTS.
MX9202438A (en) SUBSTITUTED 3-CARBOXI STEROIDS SUBSTITUTED IN POSITION 17 BETA, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
AR005916A1 (en) OXADIAZOLE AND TIADIAZOLE COMPOUNDS, THEIR USE, PROCEDURES FOR PREPARING THEM, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND A USEFUL INTERMEDIATE COMPOUND
MXPA04005076A (en) 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists.
PE20021018A1 (en) DERIVATIVES OF ß - CARBOLINE
MXPA04005313A (en) Aminotetralin derivatives as muscarinic receptor antagonists.
AR011011A1 (en) COMPOUNDS OF 3- [PIPERIDIN-4-IL] - AND 3- [1,2,3,6-TETRAHIDROPIRIDIN-4-IL] - PIRROL [3,2-B] -PIRIDINE-5-SUBSTITUTED USEFUL AS RECEPTOR AGONISTS 5-TH (1F), PROCEDURE FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS FORMULATED WITH SUCH COMPOUNDS
MX9306394A (en) DERIVATIVES OF BENZOFURANO, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM
DE602004016177D1 (en) METHYLINDOLE AND METHYLPYRROLOPYRIDINE AS ALPHA-1-ADRENERGE AGONISTS

Legal Events

Date Code Title Description
FB Suspension of granting procedure